Yeast-two-hybrid based high-throughput screening to discover SARS-CoV-2 fusion inhibitors by targeting the HR1/HR2 interaction

The continuous emergence of SARS-CoV-2 variants as well as other potential future coronavirus has challenged the effectiveness of current COVID-19 vaccines. Therefore, there remains a need for alternative antivirals that target processes less susceptible to mutations, such as the formation of six-he...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Jing Zhang, Dongsheng Li, Wenwen Zhou, Chao Liu, Peirong Wang, Baoqing You, Bingjie Su, Keyu Guo, Wenjing Shi, Tin Mong Timothy Yung, Richard Yi Tsun Kao, Peng Gao, Yan Li, Shuyi Si
Format:	Artigo
Sprog:	Inglês
Udgivet:	Elsevier 2025-09-01
Serier:	Acta Pharmaceutica Sinica B
Fag:	SARS-CoV-2 HR1/HR2 interaction Yeast-two-hybrid High-throughput screening IMB-9C Fusion inhibitor
Online adgang:	http://www.sciencedirect.com/science/article/pii/S221138352500454X
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!